Market
Synopsis of the Global Viral Gastroenteritis Market
Viral gastroenteritis is one of
the common gastrointestinal disease across the globe. It is a communicable
disease transmitted through contaminated food or water and direct contact with
the infected person. Notovirus is the common cause of viral gastritis in
various developed and developing countries across the globe.
Rising prevalence of
gastrointestinal disease across the globe, demand for new drugs for the
treatment and increasing expenses on research and development in
gastroenterology fuel the market growth. Additionally, the growing concerns
about the spread of the disease among children and an urgent need to manage viral
gastroenteritis also contribute to the market growth.
Fierce competition among key
market players acts as a barrier for the new entrant in the market.
The global viral gastroenteritis
market is expected to grow at a CAGR of 7.5% during the forecast period.
Bacterial resistance to commonly
used antibiotics such as penicillin and amoxicillin may be the leading restrain
for the growth of the market. Fierce competition among key market players acts
as a barrier for the new entrant in the market.
According to the World Health
Organization (WHO), diarrheal diseases are a major cause of hospitalizations
and child deaths globally.
Key Players
Some of the key players in this
market are Valeant Pharmaceuticals International Inc. (U.S.), Janssen Global
Services, LLC U.S.), Takeda Pharmaceutical (Japan), Bayer AG (Germany), Sanofi
(France), Allergan (Ireland), GlaxoSmithKline (U.S.), Abbott (U.S.), and
AstraZeneca (U.K).
Segments
The global viral gastroenteritis market is segmented on the basis of type of virus, diagnosis, drugs, indication, and end user.
Segments
The global viral gastroenteritis market is segmented on the basis of type of virus, diagnosis, drugs, indication, and end user.
On the basis of type of virus,
market is segmented into norovirus, rotavirus, astrovirus, and enteric
adenovirus.
On the basis of diagnosis, the
market is segmented into physical examination and rapid stool test.
On the basis of drugs, the market
is segmented into Antibiotics, antacids, laxatives, antimotility agents and
others. Other drugs are antiemetics and chemotherapy drugs.
On the basis of indication, the
market is segmented into watery diarrhea, vomiting, abdominal cramps and pain
and others.
On the basis of end user, the
market is segmented into hospitals, clinics, pharmaceutical companies,
diagnostic centers, ambulatory care centers and others.
Detailed
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor
Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
